These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9990409)

  • 21. Staphylococcal exotoxins are strong inducers of IL-22: A potential role in atopic dermatitis.
    Niebuhr M; Scharonow H; Gathmann M; Mamerow D; Werfel T
    J Allergy Clin Immunol; 2010 Dec; 126(6):1176-83.e4. PubMed ID: 20864149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superantigens in skin diseases.
    Saloga J; Knop J
    Eur J Dermatol; 1999; 9(7):586-90; quiz 591. PubMed ID: 10523743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of microorganisms in atopic dermatitis.
    Baker BS
    Clin Exp Immunol; 2006 Apr; 144(1):1-9. PubMed ID: 16542358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologic effects of bacterial superantigens in a xenogeneic transplantation model for psoriasis.
    Boehncke WH
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):231-2. PubMed ID: 11924833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A human-SCID mouse model for allergic immune response bacterial superantigen enhances skin inflammation and suppresses IgE production.
    Herz U; Schnoy N; Borelli S; Weigl L; Käsbohrer U; Daser A; Wahn U; Köttgen E; Renz H
    J Invest Dermatol; 1998 Mar; 110(3):224-31. PubMed ID: 9506440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic therapy in the management of atopic dermatitis.
    Belloni Fortina A; Neri L
    G Ital Dermatol Venereol; 2015 Jun; 150(3):321-5. PubMed ID: 25786482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis.
    Strange P; Skov L; Lisby S; Nielsen PL; Baadsgaard O
    Arch Dermatol; 1996 Jan; 132(1):27-33. PubMed ID: 8546480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinician's choice of antibiotics in the treatment of bacterial skin infection.
    Veien NK
    Br J Dermatol; 1998 Dec; 139 Suppl 53():30-6. PubMed ID: 9990410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superantigens in dermatology.
    Macias ES; Pereira FA; Rietkerk W; Safai B
    J Am Acad Dermatol; 2011 Mar; 64(3):455-72; quiz 473-4. PubMed ID: 21315950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vbeta-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes.
    Davison S; Allen M; Vaughan R; Barker J
    Clin Exp Immunol; 2000 Aug; 121(2):181-6. PubMed ID: 10931129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis.
    Wichmann K; Uter W; Weiss J; Breuer K; Heratizadeh A; Mai U; Werfel T
    Br J Dermatol; 2009 Aug; 161(2):300-5. PubMed ID: 19438853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriasis and bacterial superantigens--formal or causal correlation?
    Boehncke WH
    Trends Microbiol; 1996 Dec; 4(12):485-9. PubMed ID: 9004406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects.
    Tomi NS; Kränke B; Aberer E
    J Am Acad Dermatol; 2005 Jul; 53(1):67-72. PubMed ID: 15965423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu.
    Niebuhr M; Baumert K; Heratizadeh A; Satzger I; Werfel T
    Allergy; 2014 Aug; 69(8):1058-67. PubMed ID: 24894535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The keratinocyte as a target for staphylococcal bacterial toxins.
    Travers JB; Norris DA; Leung DY
    J Investig Dermatol Symp Proc; 2001 Dec; 6(3):225-30. PubMed ID: 11924832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin colonization by superantigen-producing Staphylococcus aureus in Egyptian patients with atopic dermatitis and its relation to disease severity and serum interleukin-4 level.
    Nada HA; Gomaa NI; Elakhras A; Wasfy R; Baker RA
    Int J Infect Dis; 2012 Jan; 16(1):e29-33. PubMed ID: 22040925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superantigens, steroid insensitivity and innate immunity in atopic eczema.
    Leung D
    Acta Derm Venereol Suppl (Stockh); 2005 Nov; (215):11-5. PubMed ID: 16321901
    [No Abstract]   [Full Text] [Related]  

  • 38. Can microbial superantigens influence atopic dermatitis flares?
    Alomar A
    Chem Immunol Allergy; 2012; 96():73-76. PubMed ID: 22433373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of superantigens associated with the egc locus in Staphylococcus aureus isolates from patients with atopic eczema.
    Mempel M; Lina G; Hojka M; Schnopp C; Seidl HP; Schäfer T; Ring J; Vandenesch F; Abeck D
    Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):306-9. PubMed ID: 12743832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Pathogenetic Effect of Natural and Bacterial Toxins on Atopic Dermatitis.
    Park KD; Pak SC; Park KK
    Toxins (Basel); 2016 Dec; 9(1):. PubMed ID: 28025545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.